Markets:

Overview

News

Currencies

International

Treasuries

Boston Scientific (NY:BSX)

75.81 +1.69 (+2.28%)

Streaming Delayed Price Updated: 12:28 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

23 24 Next >

“Power Nickel (TSX.V: PNPN) (OTCQB: PNPNF) Announces Dividend – MIGI, PRFX, PBM, CSDX Stocks Trending Now!”

December 05, 2024

Via AB Newswire

(BSX) - Analyzing Boston Scientific's Short Interest ↗

December 03, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 02, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 29, 2024

Via Benzinga

$100 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today ↗

November 25, 2024

Via Benzinga

Key Takeaways From Boston Scientific Analyst Ratings ↗

November 18, 2024

Via Benzinga

NYSE:BSX may be ready to breakout. ↗

November 12, 2024

Technical Setup: BOSTON SCIENTIFIC CORP Appears Poised for a Breakout.

Via Chartmill

$1000 Invested In This Stock 15 Years Ago Would Be Worth $11,000 Today ↗

October 29, 2024

Via Benzinga

Why Is Medical Device Giant Boston Scientific Stock Trading Higher On Monday? ↗

November 18, 2024

Boston Scientific's latest trial shows safety and efficacy endpoints for stroke prevention in atrial fibrillation patients.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 13, 2024

Via Benzinga

Don’t Confuse Brains With A Bull Market, Or Price With Value ↗

November 10, 2024

If you are interested in the stock market, maybe it is time to stop focusing on The Fed.

Via Talk Markets

Why is Boston Scientific Stock Trading Lower On Wednesday? ↗

October 30, 2024

Boston Scientific's ACURATE IDE trial results showed a 16.16% composite rate for mortality, stroke, or rehospitalization, not meeting non-inferiority versus controls.

Via Benzinga

Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review ↗

October 25, 2024

The major indexes were mixed for the week.

Via Investor's Business Daily

Behind the Scenes of Boston Scientific's Latest Options Trends ↗

October 23, 2024

Via Benzinga

Boston Scientific Pauses Enrollment In Farapulse Study In Drug-Naive Patients With Irregular Heart Rhythm ↗

October 23, 2024

Boston Scientific's AVANT GUARD trial evaluates the FARAPULSE PFA System for treating persistent atrial fibrillation, pausing enrollment to assess trial observations.

Via Benzinga

Wall Street Slumps For Third Straight Day As Investor Sentiment Fades, Dollar Strength Resumes, Boeing Disappoints: What's Driving Markets Wednesday? ↗

October 23, 2024

Wall Street is on track for its third consecutive day of losses as investors grow cautious about risky assets, awaiting more clarity on U.S. fiscal and monetary policies and scrutinizing the latest...

Via Benzinga

Boston Scientific Q3 Earnings: Revenue And EPS Beat, Lifts Annual Forecast On Strong Demand For Heart Devices ↗

October 23, 2024

Boston Scientific exceeded Q3 expectations with $4.21 billion revenue and $0.63 EPS. Cardiovascular sales rose 25%, and 2024 growth guidance was updated.

Via Benzinga

Boston Scientific Earnings, Sales Top Q3 Views; Stock Eyes High ↗

October 23, 2024

The medtech giant beat on the top and bottom line early Wednesday.

Via Investor's Business Daily

Boston Scientific's Options Frenzy: What You Need to Know ↗

October 21, 2024

Via Benzinga

Critical Insights From Boston Scientific Analyst Ratings: What You Need To Know ↗

October 21, 2024

Via Benzinga

US Hospitals Face Critical IV Fluid Shortage After Baxter Facility Shuts Down Due To Hurricane Helene ↗

October 18, 2024

The U.S. faces a critical shortage of IV fluids due to Hurricane Helene's damage to Baxter's North Carolina plant, forcing hospitals to delay surgeries. Federal efforts to rebuild and import supplies...

Via Benzinga

This Boston Scientific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗

October 18, 2024

Via Benzinga

Solventum Stock Earns 81 RS Rating ↗

October 15, 2024

Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81.

Via Investor's Business Daily

Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years ↗

October 15, 2024

Via Benzinga

Key Takeaways From Boston Scientific Analyst Ratings ↗

October 14, 2024

Via Benzinga

Performance Comparison: Boston Scientific And Competitors In Health Care Equipment & Supplies Industry ↗

October 07, 2024

Via Benzinga

Is BOSTON SCIENTIFIC CORP Ready to Break Out of Its Range? ↗

October 02, 2024

BOSTON SCIENTIFIC CORP (NYSE:BSX) has a good technical rating of 10 out of 10 and could possibly break out.

Via Chartmill

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $8,100 Today ↗

September 26, 2024

Via Benzinga

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' ↗

October 10, 2024

Goldman Sachs identifies 18 stocks for potential earnings upside and advises options-based strategies in a volatile market. 10% upside for S&P 500.

Via Benzinga

Topics Stocks

Boston Scientific: Why This MedTech Giant Isn’t Slowing Down

September 17, 2024

Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs.

Via MarketBeat

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Boston Scientific (NY:BSX)

All News about Boston Scientific

Starting at $3.75/week.

Subscribe Today